✦ LIBER ✦

Docetaxel and exisulind in hormone-refractory prostate cancer

✍ Scribed by Christopher W Ryan; Walter M Stadler; Nicholas J Vogelzang

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase I/II dose-escalation study of ex

✍ Christopher W. Ryan; Walter M. Stadler; Nicholas J. Vogelzang 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 101 KB

A Phase II Study of Estramustine, Doceta

✍ Nancy A. Dawson; Susan Halabi; San-San Ou; David D. Biggs; Anne Kessinger; Nicho 📂 Article 📅 2008 🏛 CIG Media Group, LP. 🌐 English ⚖ 130 KB

Docetaxel for hormone-refractory prostat

✍ Ian Haines 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 44 KB

Docetaxel for hormone-refractory prostat

✍ Jan-Erik Damber; Gunnar Aus 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 76 KB

Docetaxel and zoledronic acid in patient

✍ Dimitri Vordos; Bernard Paule; Francis Vacherot; Yves Allory; Laurent Salomon; A 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 70 KB

Docetaxel, low-dose estramustine, and do

✍ Yoshihiro Wada; Ken Kikuchi; Wataru Takahashi; Jiro Honda; Juro Nakanishi; Koich 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 409 KB